trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Sildenafil acts as a PDE5 inhibitor to boost nitric oxide signaling.

the verdict
REFUTED
the evidence says no
Recorded sources
0 sources for · 4 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Sildenafil acts as a PDE5 inhibitor to boost nitric oxide signaling?

No. Sildenafil does not boost nitric oxide signaling directly; rather, it acts as a phosphodiesterase 5 (PDE5) inhibitor that prevents the breakdown of cGMP downstream of nitric oxide.

Verdict: REFUTED · 0 sources for, 4 against · Last checked

The analysis

The claim states that sildenafil acts as a PDE5 inhibitor to boost nitric oxide signaling. Mechanistically, sildenafil does not increase nitric oxide (NO) levels or boost NO signaling directly; instead, it inhibits phosphodiesterase 5 (PDE5) to prevent the degradation of cGMP, thereby augmenting downstream cGMP signaling after nitric oxide has activated soluble guanylyl cyclase. The retrieved papers consistently clarify that sildenafil enhances the downstream cGMP pathway rather than boosting NO itself.

Evidence against · 4
2026
Sildenafil is described as a phosphodiesterase type 5 inhibitor that enhances nitric oxide-cyclic guanosine monophosphate signaling rather than directly boosting nitric oxide itself.
Get citation
J, F., M, S., D, C., C, Z., & A, S. (2026). Sildenafil in bronchopulmonary dysplasia-associated pulmonary hypertension: developmental and translational insights.. doi.org. https://doi.org/10.1038/s41390-026-05480-9

See more details
More against · 3
2026
PDE5 inhibitors such as sildenafil exert their effects by augmenting the downstream nitric oxide-cyclic guanosine monophosphate signaling pathway rather than boosting nitric oxide production.
Get citation
AM, E. & SS, S. (2026). Phosphodiesterase Type-5 Inhibitors and Glaucoma.. doi.org. https://doi.org/10.1097/iio.0000000000000630

2026
Nitric oxide activates soluble guanylyl cyclase to produce cGMP, which is then degraded by PDEs; sildenafil inhibits PDE to prolong this signaling rather than boosting upstream nitric oxide.
Get citation
L, T., K, S., M, T., A, F., S, F., R, F., & C, d. W. (2026). cGMP Signaling in Arterioles Revealed by FRET-Based Real-Time Measurement in Mice In Vivo.. doi.org. https://doi.org/10.1111/apha.70317

2026
The compound acts downstream on the NO-cGMP-PDE5 pathway by inhibiting PDE5 rather than boosting nitric oxide signaling itself.
Get citation
S, I., P, K., T, Y., M, N. T., P, K., K, J., S, C., R, P., & S, S. (2026). <i>Mucuna pruriens</i> var. <i>pruriens</i> Ethanolic Seed Extract Enhances Erectile Function-Related Mechanisms: Integrated In Vitro and In Vivo Evidence.. doi.org. https://doi.org/10.3390/biology15161348

What does the evidence say?

The claim states that sildenafil acts as a PDE5 inhibitor to boost nitric oxide signaling. Mechanistically, sildenafil does not increase nitric oxide (NO) levels or boost NO signaling directly; instead, it inhibits phosphodiesterase 5 (PDE5) to prevent the degradation of cGMP, thereby augmenting downstream cGMP signaling after nitric oxide has activated soluble guanylyl cyclase. The retrieved papers consistently clarify that sildenafil enhances the downstream cGMP pathway rather than boosting NO itself.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work